Layer 1
Bgma

Refine

E.g., 23/09/2020
E.g., 23/09/2020

Refine

Refine

E.g., 23/09/2020
E.g., 23/09/2020

BGMA

The report outlined a “COVID-19 recovery roadmap” for the life sciences sector
A 24-page document published this month addressed to the life sciences COVID-19 response group has called for community pharmacy to play a wider role...
25/06/2020 9
Four items from the Evorel range were out of stock in February 2020
HRT shortages have been a headache for pharmacy teams for the last few years. Not only are patients affected when their medicines are unavailable,...
27/02/2020 9
Warwick Smith: The introduction of FMD has had a detrimental impact on manufacturing capability
Mr Smith expressed his disapproval of the anti-counterfeit medicines legislation during the annual Sigma conference in Cebu in the Philippines...
18/02/2020 6
The BGMA welcomes government pledges to keep NHS “off the table” in trade negotiations
It is “critical” that the government resists any US proposals to “change patent or exclusivity provisions” that could delay the entry of generic and...
11/02/2020 0
Warwick Smith: Stockpiling six weeks' worth of medicines will not be enough to prevent disruption
The warning comes the week after the Department of Health and Social Care (DH) announced a £25 million contract to set up an express freight service...
21/08/2019 2
At one level, the UK medicines supply chain – from manufacturer to wholesaler to community pharmacies – is a relatively simple one. The originator of...
30/07/2019 3
Warwick Smith: I suspect the FMD is having an impact already
The EU’s anti-counterfeit legislation, the Falsified Medicines Directive (FMD) – which requires all pharmacies to be able to scan barcodes on...
06/03/2019 13
EXCLUSIVE
warwick smith BGMA director
The Human Medicines (Amendment) Regulations 2019 order – which came into force on February 9 – includes provisions to allow pharmacists to dispense...
04/03/2019 8
The focus on the UK’s impending exit from the European Union has generated significant and widespread planning and preparation, particularly around...
01/03/2019 0
BGMA: Up to 120 products were affected by the suspension of two supplier's manufacturing licences
Last September, the Pharmaceutical Services Negotiating Committee (PSNC) announced it was in "urgent discussions" with the Department of Health and...
08/05/2018 1

Pages